• Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Menu
  • Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Facebook
PLACENTAL MYELOID CELL POPULATION ALTERATIONS PRECEDE LABOR AND IN PREGNANCIES COMPLICATED BY PREECLAMPSIA  
Home ‹ 2014 Abstracts ‹ PLACENTAL MYELOID CELL POPULATION ALTERATIONS PRECEDE LABOR AND IN PREGNANCIES COMPLICATED BY PREECLAMPSIA  

Rivka Frankel, Gili Paz, Shay Hantisteanu, Ofer Limonad, Mordechai Hallak, Ofer Fainaru

Laboratory for Reproductive Immunology, Department of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Faculty of Medicine, Technion – Israel Institute of Technology, Israel

Introduction: Immature myeloid cells (IMCs) are generated in the bone marrow and expand

in malignant states. We have shown that IMCs populate the placenta and actively promote angiogenesis in mice and humans. Dendritic cells (DCs) that can differentiate from IMCs, are

immune cells that coordinate immune responses. They were shown to promote angiogenesis

during early pregnancy, especially during implantation. Very little is known about their function in the placenta and in the latter part of pregnancy when significant angiogenesis takes part. The pathophysiology of preeclampsia (PE) may be attributed to impaired placentation and angiogenesis during early pregnancy.  This in turn may lead to increased blood supply demands by an hypoxic fetoplacental unit in the latter part of pregnancy.

We sought to determine whether alterations in myeloid cell populations within the placenta, i.e IMCs and/or DCs, precede the onset of delivery and in pregnancy complications such as PE.

Materials and methods: Human placentas were obtained from normal vaginal deliveries (NVD) and cesarean-sections (CS) or from pregnancies complicated by PE. Placentas were immunostained and analyzed using flow cytometry.

Results: The DC population in the human placenta was higher in placentas derived from NVD  compared to elective CS (6.7±3.36% vs. 4.7±1.98%, n=41, P=0.03).

The IMC population in placentas derived from patients with preeclampsia was significantly higher as compared with those obtained from healthy controls (17.7±7.35% vs. 9.4±3.8%, n=14, P=0.018).

Conclusions: In human pregnancies, the DC population increases prior to labor (NVD), as compared to placentas obtained in the absence of labor (CS). The possibility that the onset of labor and delivery is preceded by the maturation of IMCs into DCs is intriguing. In preeclampsia, we observed an increase in the IMC population within the placenta. This may result from a hypoxic placenta and the need for increased angiogenesis. The roles of IMCs in other pregnancy complications such as IUGR and pre-term labor are the subject of our current study.

« Previous
Next »
Powered by Netmii and Art + Web
All rights reserved to ISPR -Israel Society for Placental Research
Scroll to top